Types, Management and Factors associated to the Outcome of Congenital Anomalies among Neonates in the Neonatal Intensive Care Unit of the Limbe Regional Hospital
Keywords:
Abnormalities, Congenital, Hospital, Limbe Regional Hospital, Neonates, OutcomeAbstract
Background: Congenital abnormalities are a major contributor to perinatal and infant morbidity and mortality. The impact is more severe in countries of low socio-economic status with majority of infants who die from congenital anomalies. Epidemiologists have reported numerous investigations of the prevalence and etiology of congenital anomalies, but analyses of mortality have focus on the contribution of these disorders to perinatal and infant death rates rather than to the survival of affected infants. The aim or objectives was to determine the prevalence, associated factors to outcomes of congenital anomalies among neonates in the Neonatal unit of the Limbe Regional Hospital from 2017 to 2022.
Method: This was a hospital-based retrospective study conducted from November 2022 to July 2023. A data extraction form was used to collect data from 2815 complete neonatal files admitted between 2017 and 2022 using an exhaustive sampling technique. Incomplete files were excluded. Ethical clearance was obtained from the University of Buea, faculty of health sciences Institutional review board, administrative clearances were obtained from the South West Regional Delegation of Public Health, and Limbe Regional Hospital. Data was entered using MS Excel, and exported to SPSS version 25 for analysis. Univariate analysis was done using descriptive statistics. Chi square test was used to test for association between variables while Logistic and cox regression models were used to test for significant determinants and outcome of congenital abnormalities (α=0.05).
Results: Congenital anomalies accounted for (3.5%) neonatal hospital admissions in the Limbe Regional Hospital. As for the management (34.7%) of the neonates with congenital anomaly were on medical treatment while (22.4%) underwent surgical procedures. The average period of hospital stay was 6.450±9.324 days. From 2017 to 2022, majority of the neonates 76.5% got discharged while (18.4%) died. Congenital abnormalities accounted for 5.8% of the total neonatal deaths with majority of the birth defect fatalities occurring during the neonatal period. The highest rate of mortality in this study was found in post-surgical cases (61.1%). Babies with nervous system abnormalities were found to have the poorest prognosis compared to other groups of anomalies (X2: 8.375, df:1, P: 0.004). Primiparity, male sex, forceps delivery, low birth weight and surgical management were significant risk factors for mortality.
Conclusion: Congenital anomaly is a major indication for neonatal admissions and mortality in the Limbe Regional Hospital. The highest rate of mortality in this study was found in post-surgical cases. Babies with nervous system abnormalities were found to have the poorest prognosis There is the need to establish a surveillance system for congenital anomaly and efforts should be made to raise awareness of the occurrence and risk factors of congenital anomaly in Cameroon to improve on the outcome.
References
1. World Health Organization, World Bank (Eds.), World report on disability. World Health Organization, Geneva, Switzerland. 2012. Available at www.who.int Accesses 9-05-23.
2. Khan, A.A., Khattak, T.A., Shah, S.H.A., Roshan, E., Haq, A. Pattern of congenital anomalies in the newborn. J Rawal Med Coll 2012. 16, 171–173.
3. Kumar V, Abbas AK, Aster JC, tra A. Genetic and pediatric diseases. In: editors. Robbins Basic Pathology. 9th ed. Philadelphia: Elsevier; 2013. pp. 243-298.
4. WHO/CDC/ICBDSR. Birth Defects Surveillance: A Manual for Programme Managers. Geneva: World Health Organization; 2014. Available at www.who.int Accesses 9-05-23.
5. World Health Organization: World Birth Defects Day: Many birth defects, one voice, South East Asia 2023. https://www.who.int/southeastasia/news/detail/02-03-2023-world-birth-defects-day-many-birth-defects-one-voice Accessed April 2023.
6. Cassina M, Cagnoli GA, Zuccarello D, Di Gianantonio E, Clementi M. Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation. European Journal of Medical Genetics. 2017;60(1):22-31
7. Jones KL, Jones MC, del Campo Casanelles. Fetal hydantoin syndrome (fetal dilantin syndrome). In: Smith’s Recognizable Patterns of Human Malformation. 7th ed. Philadelphia, PA: Elsevier Saunders; 2013. p. 734.
8. Van Rooij IA, Miller RK, Zielhuis GA, de Jong-van den Berg LT, Roeleveld N. Teratogenic mechanisms of medical drugs. Human Reproduction Update. 2010;16(4):378-394.
9. Thorpe PG, Gilboa SM, Hernandez-Diaz S, Lind J, Cragan JD, Briggs G,. Medications in the first trimester of pregnancy: Most common exposures and critical gaps in understanding fetal risk. Pharmacoepidemiology and Drug Safety. 2013;22:1013-1018.
10. Van Gelder MMHJ, de Jong-van den Berg LTW, Roeleveld N. Drugs associated with teratogenic mechanisms. Part II: A literature review of the evidence on human risks. Human Reproduction. 2014;29:168-183.
11. Lazarus E, Debenedectis C, North D, Spencer PK, Mayo-Smith WW. Utilization of imaging in pregnant patients: 10-year review of 5270 examinations in 3285 patients—1997-2006. Radiology. 2009;251:517-524.
12. Mah Mungyeh E, Chiabi A, Tchokoteu Pouasse FL. Neonatal mortality in a referral hospital in Cameroon over a seven year period: trends, associated factors and causes. African Health Sciences 2020, Vol 14 Issue 3.
13. Wrixon AD. New ICRP recommendations. Journal of Radiological Protection. 2008;28:161-168.
14. Calado AM, Dos Anjos Pires M. An overview of teratology. Methods in Molecular Biology. 2018;1797:3-32.
15. Longhurst W, Ernst J, Burd L. Fetal alcohol exposure and development of the integument. Research and Reports in Neonatology. 2016;6:25-32.
16. Puepi YDF, Monono N, Eposse C,. Hospital Outcome of Preterm Babies at the Regional Hospital Limbe: A 4-Year Retrospective Study. J Pediatr Neonatal. 2022; 4(4): 1.
17. EUROCAT.http://www.eurocatnetwork.eu/aboutus/datacollection/guidelinesforregistration/malformationcodingguides. Accessed 19 May 2023
18. Lawoyin TO, Onadeko MO, Asekun-Olarinmoye EO. Neonatal mortality and perinatal risk factors in rural southwestern Nigeria: a community-based prospective study. West Afr J Med. 2010;29:19–23.
19. Nii-Amon-Kotei, B., &Baffoe-Bonnie, B. Congenital malformations in Kumasi, Ghana: Prognosis for surgical cases. Pediatric Surgery International (1991), 6(1), 68–70.
20. Grønborg, T. K., Schendel, D. E., and Parner, E. T. Recurrence of autism spectrum disorders in full- and half-siblings and trends over time: a population-based cohort study. JAMA Pediatr (2013), 167, 947–953.
21. Betty Anane‑Fenin, Douglas AninngOpoku, Lawrence Chauke. Prevalence, Pattern, and Outcome of Congenital Anomalies Admitted to a Neonatal Unit in a Low‑Income Country—a Ten‑Year Retrospective Study. Maternal and Child Health Journal 2023. 25(6):10-16.
22. Nii-Amon-Kotei, B., &Baffoe-Bonnie, B. Congenital malformations in Kumasi, Ghana: Prognosis for surgical cases. Pediatric Surgery International (1991), 6(1), 68–70.
23. Lawal TA, Adeleye AO. Determinants of folic acid intake during preconception and in early pregnancy by mothers in Ibadan, Nigeria. Pan Afr Med J. 2014 Oct 1;19:113.
24. World health organization. Management of birth defects and haemoglobin disorders: report of a joint WHO-March of dimes meeting. Geneva, Switzerland, Geneva: WHO; 2006.
25. Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE,. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post 2015 priorities: an updated systematic analysis. Lancet. 2015;385:430–40.
26. Gedamu, S., Sendo, E. G., &Daba, W. Congenital anomalies and associated factors among newborns in Bishoftu General Hospital, Oromia, Ethiopia: A retrospective study. Journal of Environmental and Public Health (2021).
27. Adams MM, Greenberg F, Khoury MJ,. Survival of infants with spinal bifida—Atlanta, 1972–1979. Am J Dis Child 1985;139:518–23.
28. Wren C, O’Sullivan JJ. Survival with congenital heart disease and need for follow up in adult life. Heart 2001; 85:438–43.
29. Samanek M, Voriskova M. Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15-year survival: a prospective Bohemia survival study. Pediatr Cardiol 1999; 20:411–17
